Occupe actuellement un poste chez Fate Therapeutics Inc
Position | Company | Period |
---|---|---|
Chief Scientific Officer | Fate Therapeutics Inc | 1 mai 2015 - |
Chief Research Officer | Fate Therapeutics Inc | 1 janvier 2015 - 1 mai 2015 |
Chief Technology Officer | Fate Therapeutics Inc | 1 février 2009 - 1 janvier 2015 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2021-03-09 | 2021-03-08 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
800
-1.1%
86,7069 360 USD |
800 -1.1% | 86,70 | 69 360 USD | |
2021-03-09 | 2021-03-08 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
2 900
-3.8%
85,50247 956 USD |
2 900 -3.8% | 85,50 | 247 956 USD | |
2021-03-09 | 2021-03-08 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
2 728
-3.4%
84,20229 705 USD |
2 728 -3.4% | 84,20 | 229 705 USD | |
2021-03-09 | 2021-03-08 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
2 480
-3.0%
83,46206 989 USD |
2 480 -3.0% | 83,46 | 206 989 USD | |
2021-03-09 | 2021-03-08 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
2 993
-3.5%
81,60244 224 USD |
2 993 -3.5% | 81,60 | 244 224 USD | |
2021-03-09 | 2021-03-08 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
5 174
-5.7%
80,73417 722 USD |
5 174 -5.7% | 80,73 | 417 722 USD | |
2021-03-09 | 2021-03-08 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
4 627
-4.9%
79,58368 236 USD |
4 627 -4.9% | 79,58 | 368 236 USD | |
2021-03-09 | 2021-03-08 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
3 298
-3.4%
78,60259 236 USD |
3 298 -3.4% | 78,60 | 259 236 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
871
-1.0%
109,6595 509 USD |
871 -1.0% | 109,65 | 95 509 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
1 050
-1.2%
110,76116 296 USD |
1 050 -1.2% | 110,76 | 116 296 USD | |
2021-01-12 | 2021-01-11 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
1 332
-1.5%
111,62148 673 USD |
1 332 -1.5% | 111,62 | 148 673 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
151
-0.2%
114,7617 328 USD |
151 -0.2% | 114,76 | 17 328 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
872
-1.0%
115,80100 977 USD |
872 -1.0% | 115,80 | 100 977 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
2 451
-2.7%
117,15287 144 USD |
2 451 -2.7% | 117,15 | 287 144 USD | |
2021-01-12 | 2021-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
2 755
-3.0%
117,60323 985 USD |
2 755 -3.0% | 117,60 | 323 985 USD | |
2020-11-16 | 2020-11-16 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
14 781
-13.7%
52,40774 514 USD |
14 781 -13.7% | 52,40 | 774 514 USD | |
2020-11-16 | 2020-11-16 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
5 287
-4.7%
51,60272 825 USD |
5 287 -4.7% | 51,60 | 272 825 USD | |
2020-11-16 | 2020-11-16 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
4 932
-4.2%
50,37248 407 USD |
4 932 -4.2% | 50,37 | 248 407 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
5 713
-4.6%
37,12212 074 USD |
5 713 -4.6% | 37,12 | 212 074 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
17 887
-12.6%
36,11645 909 USD |
17 887 -12.6% | 36,11 | 645 909 USD | |
2020-09-16 | 2020-09-14 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
1 400
-1.0%
35,4049 557 USD |
1 400 -1.0% | 35,40 | 49 557 USD | |
2020-01-10 | 2020-01-08 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
5 700
-3.8%
20,70117 986 USD |
5 700 -3.8% | 20,70 | 117 986 USD | |
2020-01-02 | 2019-12-30 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
100
-0.1%
20,342 034 USD |
100 -0.1% | 20,34 | 2 034 USD | |
2020-01-02 | 2019-12-30 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
24 900
-16.7%
19,49485 393 USD |
24 900 -16.7% | 19,49 | 485 393 USD | |
2019-10-16 | 2019-10-15 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
11 800
-8.7%
14,29168 593 USD |
11 800 -8.7% | 14,29 | 168 593 USD | |
2019-06-28 | 2019-06-27 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
12 500
-8.4%
20,21252 610 USD |
12 500 -8.4% | 20,21 | 252 610 USD | |
2019-03-29 | 2019-03-28 |
Fate Therapeutics Inc
(FATE)
|
VP Vente planifiée |
12 500
-8.4%
16,94211 703 USD |
12 500 -8.4% | 16,94 | 211 703 USD | |
2017-10-17 | 2017-10-16 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
700
-0.8%
4,082 856 USD |
700 -0.8% | 4,08 | 2 856 USD | |
2017-10-17 | 2017-10-13 |
Fate Therapeutics Inc
(FATE)
|
V Vente |
12 525
-12.1%
3,8648 347 USD |
12 525 -12.1% | 3,86 | 48 347 USD |